Skip to main navigation
Accessibility
Company
About Us
Our Team
Board of Directors
Scientific Advisory Board
Contact Us
Our Strategy
Scientific Platform
Therapeutic Areas
Manufacturing
Gene Regulation
Research & Development
Pipeline
Clinical Trials
Posters & Publications
Patients & Families
Investors & Media
Overview
News Releases
Events & Presentations
Stock Information
Corporate Governance
Financial Information
Investor Resources
Join Our Team
Investors &
Media
Investors & Media
Overview
News Releases
Events & Presentations
Stock Information
Corporate Governance
Financial Information
Investor Resources
Stockholder Tools
Print Page
RSS Feeds
Email Page
Email Alerts
Top-Line Data from the MGT009 Phase 1/2 Clinical Study of Botaretigene Sparoparvovec (AAV-RPGR)
June 28, 2022 at 8:00 AM EDT
Listen to Webcast
Supporting Materials
View Presentation
510.8 KB
Investors & Media
Overview
News Releases
Events & Presentations
Stock Information
Corporate Governance
Financial Information
Investor Resources
Stockholder Tools
Print Page
RSS Feeds
Email Page
Email Alerts
